Your browser doesn't support javascript.
Rapid growth in the COVID-19 era.
Lee, Yerim; Ng, Michelle; Daniel, Kristin; Wayne, Elizabeth.
  • Lee Y; Department of Biomedical Engineering, and Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA USA.
  • Ng M; Department of Biomedical Engineering, and Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA USA.
  • Daniel K; Department of Biomedical Engineering, and Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA USA.
  • Wayne E; Department of Biomedical Engineering, and Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA USA.
MRS Bull ; 46(9): 847-853, 2021.
Article in English | MEDLINE | ID: covidwho-1686190
ABSTRACT
ABSTRACT From Operation Warp Speed to the lipid mRNA vaccine, the COVID-19 pandemic has been a watershed moment for technological development, production, and implementation. The scale and pace of innovation and global collaboration has likely not been experienced since World War II. This article highlights some of the engineering accomplishments that occurred during the pandemic. We provide a broad overview of the technological achievements in vaccine design, antibody engineering, drug repurposing, and rapid diagnostic testing. We also discuss what the future of these technologies and the future of large-scale collaborations might look like moving forward.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study Topics: Vaccines Language: English Journal: MRS Bull Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study Topics: Vaccines Language: English Journal: MRS Bull Year: 2021 Document Type: Article